Edematous Fibrosclerotic Panniculopathy (EFP) clinical trials at UCSD
1 in progress, 0 open to eligible people
Sorry, in progress, not accepting new patients
QWO™ (CCH-aaes) is indicated for the treatment of moderate to severe cellulite in the buttocks of adult women. QWO™ (CCH-aaes)-related post-injection bruising was the most common adverse reaction; generally, resolving within 21 days. Since bruising may be bothersome to patients, this study will investigate treatments that may mitigate bruising after QWO™ (CCH-aaes) treatment of cellulite in the buttocks.
San Diego, California and other locations